Title: Welcome to Celladon
Description: Celladon is a privately held biotechnology company founded with the goal of becoming the leader in developing molecular therapies for the treatment of heart failure.
Keywords:advanced heart failure, SERCA2a, MYDICAR®, SERCA2a enzyme, acute heart failure, molecular cardiology, innovative therapeutics, cardiovascular networks, cardiovascular therapeutics, recombinant adeno-associated viral rAAV vector, calcium cycling in the heart, Krisztina Zsebo, Roger Hajjar, Kenneth Chien
